Dr Chris McMillan is a virologist who researches novel vaccine designs for viruses. These viruses include Polio, seasonal influenza, flaviviruses such as Dengue virus, as well as novel and emerging viruses such as SARS-CoV-2 and highly-pathogenic avian influenza. This work utilises a range of vaccine modalities, including recombinant proteins, virus-like particles, and nucleic acid vaccines (DNA and mRNA). To maximise vaccine efficacy, these vaccines are delivered using a high-density microarray patch delivery platform, which results in targeted vaccine delivery to the immune-rich layers of the skin. Dr McMillan holds an Advance Queensland Industry Research Fellowship.